Vidna oštrina i depresivni simptomi pre i posle prve operacije katarakte kod starijih pacijenata

Filip M Radotić; Nela Đonović; Tatjana Šarenac-Vulović; Sunčica Srećković; Mirjana Petrović-Janićijević; Maja Živković

doi:10.5937/mckg50-13180

Filip M Radotić Fakultet medicinskih nauka, Univerzitet u Kragujevcu
Nela Đonović Institut za javno zdravlje, Kragujevac
Tatjana Šarenac-Vulović Fakultet medicinskih nauka, Univerzitet u Kragujevcu
Sunčica Srećković
Mirjana Petrović-Janićijević Fakultet medicinskih nauka, Univerzitet u Kragujevcu
Maja Živković Klinika za očne bolesti, Klinički centar Niš

DOI: https://doi.org/10.5937/mckg50-13180

Sažetak

Cilj: Cilj istraživanja je da detrminiše potencijalni uticaj vidne oštrine na pojavu depresivnih simptoma kod starijih pacijenata pre i posle prve operacije katarakte metodom fakoemulzifikacije.

Metode: Studija je trajala od maja 2015. god. do maja 2016. god. Studija je sprovedena na očnoj klinici, Kliničkog centra "Kragujevac". Uzorak: Ukupan broj pacijenata bio je 435, od tog broja 234 su muškarci a 201 žene. Procedure: Participanti studije popunjavali su GDS-15 upitnik. GDS-15 upitnik popunjavan je dve nedelje i četiri nedelje posle prve operacije katarakte.

Rezultati: Statistička analiza pokazala je da postoji signifikantna razlika između nivoa vidne oštrine pre i posle operacije katarakte (p<0.001). Rezultati GDS-15 skale pre i posle operacije katarakte ukazuju na signifikantnu značajnost (p<0.003). Dalje testiranje GDS-15 skale izvšeno je poređenjem različitih grupa depresivnih simptoma pre i posle operacije katrakte i to: bez simptoma depresije (p<0.003), blagi simptomi (p<0.002), umerena simptomi (p<0.001) i ozbiljni simptomi depresije (p<0.004). Izvršena je i analiza uticaja vidne oštrine neoperisanog oka. Neoperisano oko zauzima značajnu ulogu kod pojave depresivnih simptoma pre (p<0.002) i nakon (p<0.001) operacije katarakte.

Zaključak: Studija je ustanovila signifikantnu povezanost izmeču gubitka vidne oštrine i pojave depresivnih simptoma pre i posle prve operacije katarakte kod starijih pacijenata. Vidna oštrina može predstavljati značajan faktor u redukovanju pojave depresivnih simptoma kod pacijenata operisanih od katarakte

Reference

Quillen DA. Common causes of vision loss in elderly patients. Am Fam Physician. 1999;60(1):99–108.

Buch H, Vinding T, Nielsen NV. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology. 2001;108(12):2347–57.

Murthy GVS, Vashist P, John N, Pokharel G, Ellwein LB. Prevelence and causes of visual impairment and blindness in older adults in an area of India with a high cataract surgical rate. Ophthalmic Epidemiol. 2010;17(4):185–95.

Brian G, Taylor H. Cataract blindness-challenges for the 21st century. Bull World Health Organ. 2001;79(3):249–56.

Blumenthal M. Cataract surgery. Community Eye Health Int Cent Eye Health. 2002;15(42):27.

Congdon N, Vingerling JR, Klein BEK, West S, Friedman DS, Kempen J, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004;122(4):487–94.

Bollinger KE, Langston RHS. What can patients expect from cataract surgery? Cleve Clin J Med. 2008;75(3):193–6, 199–200.

Rovner BW, Casten R. Stability of visual acuity measurement in depression. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2005;13(3):255–8.

Freeman EE, Gresset J, Djafari F, Aubin M-J, Couture S, Bruen R, et al. Cataract-related vision loss and depression in a cohort of patients awaiting cataract surgery. Can J Ophthalmol J Can Ophtalmol. 2009;44(2):171–6.

Mitsonis CI, Mitropoulos PA, Dimopoulos NP, Mitsonis MI, Andriotis NM, Gitsa OE, et al. Anxiety and depression in cataract surgery: a pilot study in the elderly. Psychol Rep. 2006;99(1):257–65.

Fraser ML, Meuleners LB, Lee AH, Ng JQ, Morlet N. Vision, quality of life and depressive symptoms after first eye cataract surgery. Psychogeriatr Off J Jpn Psychogeriatr Soc. 2013;13(4):237–43.

Fraser ML, Meuleners LB, Ng JQ, Morlet N. Driver self-regulation and depressive symptoms in cataract patients awaiting surgery: a cross-sectional study. BMC Ophthalmol. 2013;13:45.

Morse JS, Schallhorn SC, Hettinger K, Tanzer D. Role of depressive symptoms in patient satisfaction with visual quality after laser in situ keratomileusis. J Cataract Refract Surg. 2009;35(2):341–6.

Lee BS, Munoz BE, West SK, Gower EW. Functional improvement after one- and two-eye cataract surgery in the Salisbury Eye Evaluation. Ophthalmology. 2013;120(5):949–55.

To KG, Meuleners LB, Fraser ML, Van Duong D, Van Do D, Huynh V-AN, et al. The impact of cataract surgery on depressive symptoms for bilateral cataract patients in Ho Chi Minh City, Vietnam. Int Psychogeriatr IPA. 2014;26(2):307–13.

Acosta-Rojas ER, Comas M, Sala M, Castells X. Association between visual impairment and patient-reported visual disability at different stages of cataract surgery. Ophthalmic Epidemiol. 2006;13(5):299–307.

Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982 1983;17(1):37–49.

Segulin N, Deponte A. The evaluation of depression in the elderly: a modification of the Geriatric Depression Scale (GDS). Arch Gerontol Geriatr. 2007;44(2):105–12.

Kurlowicz L, Greenberg SA. The Geriatric Depression Scale (GDS). AJN Am J Nurs. 2007;107(10):67–8.

Torres RM, Miralles R, Garcia-Caselles MP, Arellano M, Aguilera A, Pi-Figueras M, et al. Observational scale and geriatric depression scale of Yesavage to identify depressive symptoms in older patients. Arch Gerontol Geriatr Suppl. 2004;(9):437–42.

Fountoulakis KN, Tsolaki M, Iacovides A, Yesavage J, O’Hara R, Kazis A, et al. The validation of the short form of the Geriatric Depression Scale (GDS) in Greece. Aging Milan Italy. 1999;11(6):367–72.

Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2006;14(2):169–75.

Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4(3):173–8.

Vinkers DJ, Gussekloo J, Stek ML, Westendorp RGJ, Van Der Mast RC. The 15-item Geriatric Depression Scale (GDS-15) detects changes in depressive symptoms after a major negative life event. The Leiden 85-plus Study. Int J Geriatr Psychiatry. 2004;19(1):80–4.

Kurlowicz L. The geriatric depression scale (GDS). Insight Am Soc Ophthalmic Regist Nurses. 2000;25(1):18–9.

Kurlowicz L. The Geriatric Depression Scale (GDS). Geriatr Nurs N Y N. 1999;20(4):212–3.

Nyunt MSZ, Fones C, Niti M, Ng T-P. Criterion-based validity and reliability of the Geriatric Depression Screening Scale (GDS-15) in a large validation sample of community-living Asian older adults. Aging Ment Health. 2009;13(3):376–82.

Ishihara T, Terada S. Geriatric Depression Scale (GDS). Nihon Rinsho Jpn J Clin Med. 2011;69 Suppl 8:455–8.

van der Aa HP, Comijs HC, Penninx BW, van Rens GHMB, van Nispen RMA. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;

Qian Y, Glaser T, Esterberg E, Acharya NR. Depression and visual functioning in patients with ocular inflammatory disease. Am J Ophthalmol. 2012;153(2):370–8.

Kulkarni KM, Mayer JR, Lorenzana LL, Myers JS, Spaeth GL. Visual field staging systems in glaucoma and the activities of daily living. Am J Ophthalmol. 2012;154(3):445–51.

Rovner BW, Casten RJ. Activity loss and depression in age-related macular degeneration. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2002;10(3):305–10.

Pop-Jordanova N, Ristova J, Loleska S. Depression in ophthalmological patients. Pril Makedon Akad Na Nauk Umet Oddelenie Za Biološki Med Nauki Contrib Maced Acad Sci Arts Sect Biol Med Sci. 2014;35(2):53–8.

Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, et al. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121(11):2204–11.

Green C, Goodfellow J, Kubie J. Eye care in the elderly. Aust Fam Physician. 2014;43(7):447–50.

Senra H, Barbosa F, Ferreira P, Vieira CR, Perrin PB, Rogers H, et al. Psychologic Adjustment to Irreversible Vision Loss in Adults: A Systematic Review. Ophthalmology. 2015;

Zlatanović GD, Jovanović SV, Živković ML, Zlatanović ML, Srećković SB, Radotić FM. The efficacy of novel therapeutic modalities of isolated ocular vasculitis vs ocular vasculitis as a systemic disease. Med Glas Off Publ Med Assoc Zenica-Doboj Cant Bosnia Herzeg. 2012;9(1):66–73.

Knudtson MD. Age-Related Eye Disease, Quality of Life, and Functional Activity. Arch Ophthalmol. 2005;123(6):807.

Thylefors B, Négrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73(1):115–21.